Hemorheologic profile in healthy women undergoing controlled ovarian stimulation

Fertil Steril. 2011 Jan;95(1):327-9. doi: 10.1016/j.fertnstert.2010.07.1078. Epub 2010 Sep 15.

Abstract

We investigated the hemorheologic profile in 110 women undergoing controlled ovarian stimulation and provide evidence that smokers and women with body mass index>25 kg/m2 exhibit alterations of rheologic profile. A progressive increase of whole-blood viscosity throughout the ovarian stimulation cycle was observed; deformability and aggregation of erythrocytes decreased from baseline to the beginning of recombinant FSH administration, then remained unchanged throughout the next days; hematocrit mildly decreased during the last days of recombinant FSH administration; and fibrinogen and cholesterol levels decreased and increased, respectively, throughout the stimulation cycle.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Blood Flow Velocity / drug effects
  • Chorionic Gonadotropin / administration & dosage
  • Chorionic Gonadotropin / adverse effects
  • Erythrocyte Aggregation / drug effects
  • Erythrocyte Deformability / drug effects
  • Female
  • Fertility Agents, Female / administration & dosage
  • Fertility Agents, Female / adverse effects
  • Follicle Stimulating Hormone / administration & dosage
  • Follicle Stimulating Hormone / adverse effects
  • Hemorheology / drug effects*
  • Hormones / administration & dosage*
  • Hormones / adverse effects
  • Humans
  • Infertility, Female / epidemiology
  • Infertility, Female / therapy*
  • Leuprolide / administration & dosage
  • Leuprolide / adverse effects
  • Ovulation Induction*
  • Risk Factors
  • Sperm Injections, Intracytoplasmic*
  • Vascular Diseases / chemically induced
  • Vascular Diseases / epidemiology
  • Young Adult

Substances

  • Chorionic Gonadotropin
  • Fertility Agents, Female
  • Hormones
  • Follicle Stimulating Hormone
  • Leuprolide